arrow
J

Jennifer J. Knox

University Health Network
H指数:80
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers

LIVER-R研究方案:一项关于 durvalumab为基础方案在肝胆肿瘤患者中的全球真实世界研究

2025-11-240
OAAI
Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma

多组学全基因组表征转移性胰腺导管腺癌的拷贝数景观

2025-07-220
OA
Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial

COMPASS试验中晚期胰腺癌患者的全基因组与转录组分析

2025-07-010
OAAI
Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA

通过循环无细胞RNA微创确定胰腺导管腺癌 (PDAC) 亚型

2024-10-310
OA
Genomic and transcriptomic characterization of pancreatic cancer patients on the PASS-01 trial
2024-09-150
PRE
Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040

Nivolumab联合ipilimumab治疗先前接受索拉非尼治疗的晚期肝细胞癌患者: CheckMate 040的5年结果

2024-06-015
OAAI
Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma

循环肿瘤代谢物2-羟基戊二酸作为异柠檬酸脱氢酶 (IDH1/2) 突变型胆管癌的潜在生物标志物

2023-11-284
OAAI
BRAFΔß3-αC in-frame deletion mutants differ in their dimerization propensity, HSP90 dependence, and druggability
2023-09-012
OAAI